Billionaire investor Cathie Wood, through her ARK ETFs, made big buys of CRISPR Therapeutics on Friday, Oct. 9, and Monday, ...

The company's expertise in gene editing could lead to more breakthroughs.

A 2026 review summarizes advances in CRISPR-Cas9 precision, delivery and primary-cell engineering for genetic diseases and ...

Infant neuroblastoma is one of the most clinically paradoxical cancers in medicine. Diagnosed during the first year of life, ...

Add Yahoo as a preferred source to see more of our stories on Google. Stanford researchers have developed CRISPR-GPT, an AI-powered copilot that guides gene-editing experiments. (CREDIT: Shutterstock) ...

Crispr stock, alongside other gene-editing equities, pulled a bullish move Thursday — bounding for a breakout.

Anthropic says 950 Claude agents scanned more than 200,000 reverse transcriptases in 21 hours, identifying a novel system called ART that researchers later validated in a laboratory ...

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...

In 1948, researchers stressed a nursing mother with ice water, toe pulling, and math problems with shocks. Each time, her baby got less milk. The Old Farmer's Almanac predicts snow in the Upper ...

DELRAY BEACH, Fla., Oct. 16, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the CRISPR Market is projected to reach ...

CRISPR Therapeutics AG remains a long-term Buy, anchored by Casgevy's success and management’s execution in ex vivo gene editing. Click for more on CRSP.

Josie Zayner infamously injected herself with CRISPR on a livestream. Now her company is gene-editing horse, cat and cattle ...